Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Home » Drug Information » Recently Approved Drugs » 1996
Medical Areas: Cardiology/Vascular Diseases | Endocrinology

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Teczem (enalapril maleate/diltiazem malate)

Company: Hoechst Marion Roussel
Approval Status: Approved October 1996
Treatment Area: hypertension

General Information

Teczem has been approved for the treatment of hypertension. Teczem combines two compounds in a single tablet. Vasotec, manufactured by Merck, is the brand name for enalapril. Cardizem, manufactured by Hoechst Marion Roussel, is the brand name for diltiazem. Indicated for the initial treatment of high blood pressure, Teczem will be manufactured by Merck and marketed by Hoechst Marion Roussel.

Mechanism of Action

Teczem is the first combination product of an ACE inhibitor and a non-dihydropyridine calcium channel blocker. Non-dihydropyridine calcium channel blockers are distinguished by their heart-rate lowering action in the treatment of hypertension.

A???????????????


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.